The upregulation of VGLL family genes by LATS1/2 deletion were further confirmed in ER+ breast cancer cell lines, as well as in ER+ tissue organoids, including mammary epithelial organoids, endometrial organoids and fallopian tube organoids (Fig. 1c and Supplementary Fig. 3b–d). This evidence concerns the gene LATS1 and breast carcinoma.